Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Veteran's sinusitis with residuals of sinus surgery is now rated at the maximum schedular evaluation (50%) effective December 2, 2011. The other issues remain denied.

The deciding factor: The VA examiner found that the Veteran’s symptoms have worsened since October 28, 2006 and are now characterized by near constant headaches, pressure, purulent drainage, nasal congestion, itchy nose, watery eyes, sneezing, hoarseness, and occasional breathing difficulties.

Claimed conditions
syringoma, sinusitis with residuals of sinus surgery, Baker's cyst, left knee, strain, lumbar spine
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
50%
Decision date
November 19, 2012
Citation
1239587

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1239587.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.